20 LATEST RESOURCES (333 INDEXED)
Adverse Events with Quetiapine and Clarithromycin Coprescription: A Population-Based Retrospective Cohort Study · June 2023
Articles
Health Science Reports
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 Mg: Secondary Analysis of Outcomes in Adult Patients with Bipolar I Disorder in a Randomized, Open-Label, Parallel-Arm, Pivotal Study · June 2023
Articles
Current Medical Research and Opinion
Infant Exposure to Fluvoxamine through Placenta and Human Milk: A Case Series – A Contribution from the ConcePTION Project · May 2023
Articles
Frontiers in Psychiatry
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial · May 2023
Articles
JMIR Public Health and Surveillance
Obsessive Compulsive Disorder Due to Dexamethasone Use · May 2023
Articles
Psychiatry Research Case Reports
Association between Prenatal Antibiotic Exposure and Autism Spectrum Disorder among Term Births: A Population-Based Cohort Study · March 2023
Articles
Paediatric and Perinatal Epidemiology
Impact of Vitamin D Supplementation on Statin-Associated Muscle Symptoms (Meetings-Events) · March 2023
Abstracts
Journal of the American College of Cardiology
Risks and Benefits of Psilocybin Use in People with Bipolar Disorder: An International Web-Based Survey on Experiences of ‘Magic Mushroom’ Consumption · December 2022
Articles
Journal of Psychopharmacology
A Survey of Drug Liking and Cravings in Patients Using Sublingual or Intranasal Ketamine for Treatment Resistant Depression: A Preliminary Evaluation of Real World Addictive Potential · November 2022
Articles
Frontiers in Psychiatry
Early Onset Tardive Syndromes Associated with Lurasidone in Patients with Mood Disorders: A Case Series and Literature Review · September 2022
Articles
Journal of Affective Disorders Reports
Comparison of Extrapyramidal Symptoms among Outpatients with Schizophrenia on Long-Acting Injectable Antipsychotics · September 2022
Abstracts
Journal of Clinical Psychopharmacology
Depression, Anxiety and Adjustment Disorder among Patients with Psoriasis Receiving Systemic Agents: A Retrospective Cohort Study in Quebec, Canada · August 2022
Articles
JEADV Clinical Practice
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data from the Systolic Blood Pressure Intervention Trial (SPRINT) · July 2022
Articles
JAMA Network Open
Monitoring Patients with Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors with Methadone: A Population-Based Study · April 2022
Articles
Frontiers in Pharmacology
The Impact of Cognitive Impairment on Treatment Toxicity, Treatment Completion, and Survival among Older Adults Receiving Chemotherapy: A Systematic Review · March 2022
Articles
Cancers
Efficacy and Safety of Racemic Ketamine and Esketamine for Depression: A Systematic Review and Meta-Analysis · March 2022
Articles (Manuscripts-Versions)
PubMed Central>Expert Opinion on Drug Safety
Improving the Safety of Medicines via Digital Technology: An Assessment of the Scope and Quality of Risk Minimization Websites in the United States and United Kingdom · March 2022
Articles
Drug Safety
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up · November 2021
Articles
Journal of Child and Adolescent Psychopharmacology